2020-12-31-accounts

			Unrestricted	Restricted	Total	Total
			funds	funds	funds	funds
		Note	2020 6	2020f	2020f	2019f
Income from:
Donations and legacies			96,840		96,840	76,920
Charitable activities			573,699	75,913	649,611	898,189
Other trading activities			15,228		15,228	22,761
Investments			299		299	643
Total income			686,066	75,913	761,979	998,513
Expenditure on:
Raising funds			23,852		23,852	32,467
Charitable activities			467,239	121,197	588,436	886,775
Total expenditure			491,091	121,197	612,288	919,242
Net gains/(losses)	on investments		(104,301)		(104,301)	151,186
Net income/(expenditure)			90,674	(45,284)	45,390	230,457
Transfers between	funds	20	(200,000)	200,000
Net movement in	funds		(109,326)	154,716	45,380	230,457
Reconciliation of	funds:
Total funds brought	forward		1 190)301	187~462	1,377,763	1,147,306
Net movement in funds			(109,326)	154,716	45,390	230,457
Total funds carried forward			1,080,975	342,178	1,423,153	1,377,763

				2020		2019
		Note		5		5
Fixed assets
Intangible assets		13		3,600		4,200
Tangible assets		14		4,289		5,363
Investments		15		704,580		808,881
				712,469		818,444
Current assets
Debtors		16	470,200		427,304
Cash at bank and	in hand		570,835		529,271
			1,041,035		956,575
Creditors: amounts	falling due within one
year		17	(329,341)		(395,573)
Net current assets				711,694		561,002
Total assets less	current liabilities			1,424,163		1,379,445
Creditors: amounts	falling due after more
than one year		18		(1,010)		(1,683)
Total net assets				1,423,153		1,377,763
Charity funds
Restricted funds		20		342,178		187,462
Unrestricted funds		20		1,080,975		1,190,301
Total funds				1,423,153		1,377,783

						2020	2019
						5	8
Cash flows from operating			activities
Net cash	used in operating	activities (see		Note 24)		43,070	115,400
Cash flows from investing			activities
Dividends,	interests and rents from investments					299	643
Purchase	oftangible fixed assets					(1,805)
Net cash	(used in)/provided		by investing		activities	(1,506)	643
Cash flows from financing			activities
Net cash	provided by financing activities
Change in cash and cash			equivalents	in	the year	41,564	116,043
Cash and	cash equivalents		at the beginning		ofthe year	529,271	413,228
Cash and	cash equivalents		atthe end	of	the year (see Note 24)	570,835	529,271

Short leasehold	property	Over the period	ofthe lease
Office furniture,	fittings and	20% on the straight	line basis
equipment
Computer equipment		33% on the straight	line basis
Intangible fixed	asset	5% on the straight	line basis

3.	Income from	donations	donations	and	legacies
						Unrestricted	Total	Total
						funds	funds	funds
						2020	2020	2019
						E	E	E
	Sponsorship	donations				96,840	96,840	76,920
	Total 2019					76,920	76,920
4.	Income from	charitable		activities
						Unrestricted	Restricted	Total
						funds	funds	funds
						2020	2020	2020
						E	E	E.
	Meetings income					217,328		217,328
	Annual subscriptions					255,668		255,668
	Special Certificate Examination				income	40,806		40,806
	Clinical Research Training			Fellowship			75,913	75,913
	Practical Neurology		income			59,897		59,897
	Roger Bannister Fellowship
	Total 2020					573,699	75,913	649,612

								Unrestricted	Restricted	Total
								funds	funds	funds
								2019 F	2019f	2019f
	Meetings	income						450,873		450,873
	Annual subscriptions							233,825		233,825
	Special Certificate Examination					income		38,206		38,206
	Clinical Research		Training		Fellowship				117,724	117,724
	Practical	Neurology		income				56,630		56,630
	Roger Bannister		Fellowship						931	931
	Total 2019							779,534	118,655	898,189
5.	Income	from other		trading	activities
	Income	from fundraising			events
								Unrestricted	Total	Total
								funds	funds	funds
								2020	2020	2019
								E	E	E
	Hire and	sublet ofoffice space						15,228	15,228	16,848
	RaDar income									1,050
	Total 2020							15,228	15,228	17,898
	Total 2019							17,898	17,898
	Income	from non charitable				trading	activities
									Total	Total
									funds	funds
									2020f	2019f
	Sales of	merchandise								4,863

					Unrestricted	Total	Total
					funds	funds	funds
					2020	2020	2019
					E	F.	E
Allocated	centrally	incurred		support costs	23,852	23,852	25,396
Other trading expenses
						Total	Total
						funds	funds
						2020	2019
						F	F
Cost ofmerchandise			sold				7,071

			Grant
			funding	Support	Total
		Direct costs	(Note 9)	costs	funds
		2020	2020	2020	2020
		E	E	E
Chadtable	activities	193,207	121,197	274,031	588,435

			Grant
			funding	Support	Total
		Direct costs	(Note 9)	costs	funds
		2019	2019	2019	2019
		6	6	8	8
Charitable	activities	486,068	108,648	292,060	886,776
Analysis	ofdirect costs

						Total	Total
						funds	funds
						2020	2019
						F
Meetings	expenditure					66,638	344,287
Meetings	consultancy					44,040	48,000
General	and committee			meeting	expenses	3,691	13,686
Charles	Symonds	Prize				600	600
Educationalsupport						3,263	700
ABN representation			at other meetings				4,218
Professional subscriptions						8,075	7,311
Practical	Neurology		subscription			40,000	40,000
Specialty	Certificate		Examination		expenditure	27,000	27,266
						193,207	488,068

Analysis ofsupport cost	s (continued)
		Total	Total
		funds	funds
		2020 f	2019 F
Staff costs		183,649	188,838
Office rent, rates and service charges		58„857	51,210
Website		15,502	30,050
Office running expenses		12,904	17,716
Fellowship support costs		1,216	4,666
Computer costs		3,218	1,824
Stafftraining		199
Consultancy fees			1,800
Audit and accountancy		6,300	7,080
Loss on disposal oftangible fixed asset			3
Legal and professional		7,085	6,307
Bank charges		3,429	2,908
Finance lease charges		209	157
Loss on foreign exchange		447
Depreciation		3,478	3,063
Sundry expenses		1,392	1,834
Reallocated to fundraising	costs	(23,852)	(25,396)
		274,031	292,060

				Grants to	Total
				Individuals	funds
				2020 f.	2020f
Clinical	Research	Training	Fellowship	121,197	121,197

				Grants to	Total
				Individuals	funds
				2019	2019
				6	6
Clinical	Research	Training	Fellowship	108,648	108,648

Staffcosts
				2020	2019f
Wages and	salaries			157,221	160,259
Social security costs				10,706	12,194
Contribution	to defined	contribution	pension schemes	15,722	16,385
				183,649	188,838

2020	2019
No.	No.

Intangible assets
	Coat ofarms
	F
Cost
At 1 January 2020	12,000
At 31 December 2020	12,000
Amortisation
At 1 January 2020	7,800
Charge for the year	600
At 31 December 2020	8,400
Net book value
At 31 December 2020	3,600
At 31 December 2019	4,200

	Short-term
	leasehold	Fixtures and	Computer
	property	fittings	equipment	Total
	E	5	E	F
Cost or valuation
At 1 January 2020	19,891	26,822	4,195	50,908
Additions		517	1,287	1,804
At 31 December 2020	19,891	27,339	5,482	52,712
Depreciation
At 1 January 2020	19,890	21,804	3,851	45,545
Charge for the year		1,887	990	2,877
At 31 December 2020	19,890	23,691	4,841	48,422
Net book value
At 31 December 2020	1	3,648	641	4,290
At 31 December 2019	1	5018	344	5,363

	Listed
	investments
	6
Cost or valuation
At 1 January 2020	808,881
Revaluations	(104,301)
At 31 December 2020	704,580
Net book value
At 31 December 2020	704,580
At 31 December 2019	806,881

		2020	2019
			E
Due within one year
Arrears ofsubscriptions		3,549	1,568
Other debtors		79,417	102,367
Prepayments	and accrued income	287,457	323,369
Sponsorship	income receivable	99,777
		470,200	427,304

17.	Creditor	s: Amounts	falling	due within one y	ear
						2020	2019
						5
	Other taxation and social security					79	127
	Net obligations under		finance	leases		673	673
	Pension	fund loan payable				1,090	3,317
	Other creditors					33,757	47,446
	Accruals	and deferred	income			293,742	344,010
						329,341	395,573
	The above includes		deferred	income of F126,156 (2019 - 5123,898) relating		to annual	subscriptions
	received	in advance which may be analysed as			follows:-
						2020	2019
	Deferred	income at 1	January	2020		123,898	113,158
	Amount	deferred during the year				126,156	123,898
	Amounts	released to	incoming	resources		(123,898)	(113,158)
						126,156	123,898
18.	Creditors: Amounts		falling due after more than one year
						2020 f.	2019f
	Net obligations under		finance	leases		1,010	1,683
19.	Financial instruments
						2020	2019
							5
	Financial assets
	Financial	assets measured at		fair value through	income and expenditure	570,835	529,271

							Balance at
		Balance at 1					31
		January			Transfers	Gains/	December
		2020	Income	Expenditure	in/out	(Losses)	2020
		6	E	K	E	F	E
Unrestricted
funds
General	Funds	531,420	686,066	(491,091)	(200,000)		526,395
Revaluation
reserve		658,881				(104,301)	554,580
		1,190,301	686,066	(49'l,091)	(200,000)	(104,301)	1,080,975
Restricted
funds
Clinical
Research
Training
Fellowship		171,719	75,913	(121,197)	200,000		326,435
Roger Bannister
Fellowship		15,743					15,743
		187,462	75,913	(121,197)	200,000		342,178
Total offunds		1,377,763	761,979	(612,288)		(104,301)	1,423,153

Statement	offunds (continued)
Statement	offunds - prior year
						Balance at
		Balance at				31
		1 January			Gains/	December
		2019 F	Income	Expenditure F	(Losses)f	2019 F
Unrestricted	funds
General Funds		462,157	879,858	(810,595)		531,420
Revaluation	reserve	507,695			151,186	658,881
		969,852	879,858	(810,595)	151,186	1,190,301
Restricted funds
Clinical Research Training
Fellowship		162,643	117,724	(108,648)		171,719
Roger Bannister Fellowship		14,812	931			15,743
		177,455	118,655	(108,648)		187,462
Total offunds		1,147,307	998,513	(919,243)	151,186	1,377,763

Summary offun	ds - current year
						Balance at
	Balance at 1					31
	January			Transfers	Gains/	December
	2020	Income	Expenditure	in/out	(Losses)	2020
	6	6		E		6
General funds	1,190,301	686,066	(491,091)	(200,000)	(104,301)	1,080,975
Restricted funds	187,462	75,913	(121,197)	200,000		342,178
	1,377,763	761,979	(612,288)		(104,301)	1,423,153

					Balance at
	Balance at				31
	1 January			Gsinai	December
	2019 f.	Income f.	Expenditure f	(Losses)f	2019f
General funds	969,852	879,858	(810,595)	151,186	1,190,301
Restricted funds	177,455	118,655	(108,648)		187,462
	1,147,307	998,513	(919,243)	151,186	1,377,763

		Unrestricted	Restricted	Total
		funds	funds	funds
		2020f	2020f	2020f
Tangible	fixed assets	4,289		4,289
Intangible	fixed assets	3,600		3,600
Fixed asset investments		704,580		704,580
Current assets		547,498	493,537	1,041,035
Creditors	due within one year	(177,982)	(151,359)	(329,341)
Creditors	due in more than one year	(1,010)		(1,010)
Total		1,080,975	342,178	1,423,153

		Unrestricted	Restricted	Total
		funds	funds	funds
		2019f	2019f	2019f
Tangible	fixed assets	5,363		5,363
Intangible	fixed assets	4,200		4,200
Fixed asset investments		808,881		808,881
Current assets		577,781	378,794	956,575
Creditors	due within one year	(204,241)	(191,332)	(395,573)
Creditors	due in more than one year	(1,683)		(1,683)
Total		1,190,301	187,462	1,377,763

Reconciliation of	net movement		in funds	to net cash flow from operating	activities
					2020f	2019f
Net income fcr the	period (as per	Statement		of Financial Activities)	45,390	230,457
Adjustments for:
Depreciation charges					3,478	3,063
(Gains)/ losses on	investments				104,301	(151,186)
Dividends, interests	and rents from		investments		(299)	(642)
Decrease in stocks						4,022
Decrease/(increase)	in debtors				(42,895)	31,194
Decrease in creditors					(66,905)	(1,507)
Net cash provided	by operating	activities			43,070	115,401

		2020f	2019f
Cash	in hand	570,835	529,271
Total	cash and cash equivalents	570,835	529,271

			At 1		At 31
			January		December
			2020	Cash flows	2020
			6		F
Cash at bank and		in hand	529,271	41,564	570,835
Debt due within	1	year	(3,317)	2,227	(1,090)
Finance leases			(2,356)	673	(1,683)
			523,598	44,464	568,062

Reconcilia	tion ofmove	ments in unr	ealised gains on the investm	ent asset
				2020	2019
				5
Unrealised	gains at 1 January			658,881	507,695
Unrealised	gain/(losses)	on revaluation	at 31 December	(104,301)	151,186
Unrealised	gains at 31	December		554,580	658,881

			2020f	2019f
Not later than		1 year	32,250	32,250
Later than	1 year and not later than 5 years		64,500	96,750
			96,750	129,000

		2020f	2019 F
Donations	received	425	525
		425	525